13 Einträge gefunden

1. Correction to: Allogeneic hematopoietic cell transplantation for patients with TP53 mutant or deleted chronic lymphocytic leukemia: results of a prospective observational study

   1. Schetelig, Johannes
   2. Hoek, Jennifer
   3. Stilgenbauer, Stephan
   4. Middeke, Jan Moritz
   5. Andersen, Niels Smedegaard
   6. Fox, Christopher P
   7. Lenhoff, Stig

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
2. Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome using treosulfan based compared to other reduced-intensity or myeloablative conditioning regimens. A report of the chronic malignancies working party of the EBMT

   1. Shimoni, Avichai
   2. Robin, Marie
   3. Iacobelli, Simona
   4. Beelen, Dietrich
   5. Mufti, Ghulam J
   6. Ciceri, Fabio
   7. Bethge, Wolfgang

   2021 - Forschungsinformationssystem des UKE
3. Allogeneic hematopoietic cell transplantation for patients with TP53 mutant or deleted chronic lymphocytic leukemia: Results of a prospective observational study

   1. Schetelig, Johannes
   2. Hoek, Jennifer
   3. Stilgenbauer, Stephan
   4. Middeke, Jan Moritz
   5. Andersen, Niels Smedegaard
   6. Fox, Christopher P
   7. Lenhoff, Stig

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
4. Donor selection for a second allogeneic stem cell transplantation in AML patients relapsing after a first transplant: a study of the Acute Leukemia Working Party of EBMT

   1. Shimoni, Avichai
   2. Labopin, Myriam
   3. Finke, Jürgen
   4. Ciceri, Fabio
   5. Deconinck, Eric
   6. Kröger, Nicolaus
   7. Gramatzki, Martin

   2019 - Forschungsinformationssystem des UKE - frei zugänglich
5. Prediction of Allogeneic Hematopoietic Stem-Cell Transplantation Mortality 100 Days After Transplantation Using a Machine Learning Algorithm: A European Group for Blood and Marrow Transplantation Acute Leukemia Working Party Retrospective Data Mining Study

   1. Shouval, Roni
   2. Labopin, Myriam
   3. Bondi, Ori
   4. Mishan-Shamay, Hila
   5. Shimoni, Avichai
   6. Ciceri, Fabio
   7. Esteve, Jordi

   2015 - Forschungsinformationssystem des UKE
6. Donor lymphocyte infusions and second transplantation as salvage treatment for relapsed myelofibrosis after reduced-intensity allografting.

   1. Klyuchnikov, Evgeny
   2. Holler, Ernst
   3. Bornhäuser, Martin
   4. Kobbe, Guido
   5. Nagler, Arnon
   6. Shimoni, Avichai
   7. Könecke, Christian

   2012 - Forschungsinformationssystem des UKE
7. Unrelated stem cell transplantation after reduced intensity conditioning for patients with multiple myeloma relapsing after autologous transplantation.

   1. Kröger, Nicolaus
   2. Shimoni, Avichai
   3. Schilling, Georgia
   4. Schwerdtfeger, Rainer
   5. Bornhäuser, Martin
   6. Nagler, Arnon
   7. Zander, Axel R.

   2010 - Forschungsinformationssystem des UKE
8. Allogenic hematopoietic stem-cell transplantation with reduced-intensity conditioning in patients with refractory and recurrent multiple myeloma: long-term follow-up.

   1. Shimoni, Avichai
   2. Hardan, Izhar
   3. Ayuketang Ayuk, Francis
   4. Schilling, Georgia
   5. Atanackovic, Djordje
   6. Zeller, Wolfgang
   7. Yerushalmi, Ronit

   2010 - Forschungsinformationssystem des UKE
9. Clinical impact of human Jurkat T-cell-line-derived antithymocyte globulin in multiple myeloma patients undergoing allogeneic stem cell transplantation.

   1. Ayuketang Ayuk, Francis
   2. Perez-Simon, José A
   3. Shimoni, Avichai
   4. Sureda, Anna
   5. Zabelina, Tatjana
   6. Schwerdtfeger, Rainer
   7. Martino, Rodrigo

   2008 - Forschungsinformationssystem des UKE - frei zugänglich
10. Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch after dose-reduced conditioning and unrelated stem cell transplantation in patients with multiple myeloma.

    1. Kröger, Nicolaus
    2. Shaw, Bronwen
    3. Iacobelli, Simona
    4. Zabelina, Tatjana
    5. Peggs, Karl
    6. Shimoni, Avichai
    7. Nagler, Arnon

    2005 - Forschungsinformationssystem des UKE
11. Relapse to prior autograft and chronic graft-versus-host disease are the strongest prognostic factors for outcome of melphalan/fludarabine-based dose-reduced allogeneic stem cell transplantation in patients with multiple myeloma.

    1. Kröger, Nicolaus-Martin
    2. Perez-Simon, Jose A
    3. Myint, Han
    4. Klingemann, Hans
    5. Shimoni, Avichai
    6. Nagler, Arnon
    7. Martino, Rodrigo

    2004 - Forschungsinformationssystem des UKE
12. Deletion of chromosome band 13q14 as detected by fluorescence in situ hybridization is a prognostic factor in patients with multiple myeloma who are receiving allogeneic dose-reduced stem cell transplantation.

    1. Kröger, Nicolaus-Martin
    2. Schilling, Georgia
    3. Einsele, Hermann
    4. Liebisch, Peter
    5. Shimoni, Avichai
    6. Nagler, Arnon
    7. Perez-Simon, Jose A

    2004 - Forschungsinformationssystem des UKE
13. Low-dose thalidomide and donor lymphocyte infusion as adoptive immunotherapy after allogeneic stem cell transplantation in patients with multiple myeloma.

    1. Kröger, Nicolaus-Martin
    2. Shimoni, Avichai
    3. Zagrivnaja, Maria
    4. Ayuketang Ayuk, Francis
    5. Lioznov, Michael
    6. Schieder, Heike
    7. Renges, Helmut-Hans

    2004 - Forschungsinformationssystem des UKE